why do glp 1 agonists cause pancreatitis Glucagon-like Peptide Receptor Signaling in Acinar Cells Causes Growth-Dependent Release of Pancreatic Enzymes GLP-1–Based Therapy for Diabetes: What
Description
For full details on common and serious side effects see the Zepbound medication guide or talk to your healthcare provider or pharmacist
JAMA Oncology
2024;387:e080340
[DOI] [PMC free article] [PubMed] [Google Scholar] 187.Lin A., Ding Y., Li Z., Jiang A., Liu Z., Wong H.Z.H., Cheng Q., Zhang J., Luo P
No patients receiving GLP-1 RAs were excluded due to loss of follow-up, while 8 patients (0.2%) who did not receive GLP-1 RAs were excluded for this reason (Supplemental Table 3)
